Health Benefit Exchange Authority Executive Board John Auerbach Confirmation Resolution of 2026

26th Council Period (2025-2026) Introduced by Phil Mendelson

John Auerbach is confirmed as a voting member of the DC Health Benefit Exchange Authority Executive Board for the unexpired term through 7/6/2026, with eligibility for a 7/6/2030 t

Approved with Resolution Number R26-0430

Summary of PR 26-0691 — Health Benefit Exchange Authority Executive Board John Auerbach Confirmation Resolution of 2026

This bill is a confirmation resolution from the District of Columbia Council to appoint John Auerbach to the Health Benefit Exchange Authority (HBXA) Executive Board as a voting member.

1) Purpose and Intent

The bill confirms the appointment of John Auerbach to the DC Health Benefit Exchange Authority Executive Board.

It fills a vacant seat that was previously held by Khalid Pitts.

The appointment is for the remainder of an unexpired term ending July 6, 2026, with eligibility for a subsequent term to end July 6, 2030.

2) Key Provisions and Changes

Sec. 2: Appointment confirmed

Appointee: John Auerbach, residing at Jane Auerbach’s listed address (Ward 3).
Role: Voting member of the HBXA Executive Board.
Term: Unexpired term to 7/6/2026; subsequent term to 7/6/2030.
Vacancy: Fills the seat formerly held by Khalid Pitts.

Sec. 3: Transmission of resolution

The Council must send a copy of the adopted resolution to the nominee and to the Mayor.

Sec. 4: Effective date

The resolution takes effect immediately upon adoption.

3) Who/What Is Affected

John Auerbach: Confirmed to serve as a voting member on the DC HBXA Executive Board.

District HBXA Executive Board: Leadership composition updated to include Auerbach; ongoing governance and decision-making for the District’s Health Benefit Exchange.

Khalid Pitts: Previously held the vacated seat; this resolution explicitly fills that vacancy.

4) Procedural and Timeline Aspects

Nominating Authority: The Mayor of DC nominates John Auerbach under the Confirmation Act of 1978 and the Health Benefit Exchange Authority Establishment Act of 2011.

Confirmation Process: The bill is introduced by Council Chairman Phil Mendelson and referred to the Committee on Health (Action History shows referral on 2026-05-19; introduced on 2026-05-06).

Term Dates: Unexpired term ends 7/6/2026; next term ends 7/6/2030.

Effective Date: Immediate upon adoption.

Contextual Notes

The bill includes biographical information for John Auerbach, illustrating his extensive public health background (past roles at CDC, Massachusetts Department of Public Health, ASTHO, and leadership in public health and disease prevention).

The resolution is a formal, unicameral confirmation instrument rather than substantive policy changes; it authorizes the appointment of a governance board member.

If you’d like, I can add a brief section on John Auerbach’s relevant qualifications and how his background aligns with HBXA responsibilities.